Accueil>>Signaling Pathways>> Microbiology & Virology>> RSV>>Pentaacetylquercetin

Pentaacetylquercetin (Synonyms: NSC 115919, Peracetylated Quercetin, Quercetin Pentaacetate)

Catalog No.GC40189

La pentaacétylquercétine pourrait interagir avec la protéine F avec une énergie de liaison plus faible et une meilleure stabilité pour bloquer l'adhésion virale.

Products are for research use only. Not for human use. We do not sell to patients.

Pentaacetylquercetin Chemical Structure

Cas No.: 1064-06-8

Taille Prix Stock Qté
10mg
66,00 $US
En stock
50mg
213,00 $US
En stock
100mg
358,00 $US
En stock
500mg
1 627,00 $US
En stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Avis des clients

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Pentaacetylquercetin is a pentaacetylated derivative of the flavonoid quercetin that has diverse biological activities, including antioxidant, anti-inflammatory, and anticancer properties. It scavenges 2,2-diphenyl-1-picrylhydrazyl radicals in vitro (IC50 = 3.74 μg/ml) and inhibits iron(II) chloride-induced lipid peroxidation in rat liver mitochondria (IC50 = 20.2 μg/ml). Pentaacetylquercetin inhibits LPS-induced increases in nitrite (IC50 = 8.7 μM) and PGE2 production, as well as inducible nitric oxide synthase (iNOS) and COX-2 levels, in RAW 264.7 cells when used at concentrations of 20 and 40 μM. It also inhibits the growth of HL-60, U937, and SK-MEL-1 cells (IC50s = 38, 25, and 58 μM, respectively).

Avis

Review for Pentaacetylquercetin

Average Rating: 5 ★★★★★ (Based on Reviews and 24 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Pentaacetylquercetin

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.